Trial Details

COMPLETED
Basic Information
Clinical ID c1761
Identifier NCT04535882
Trial Title Effectiveness of Serum Leucine-rich Alpha-2 Glycoprotein Levels on IBD
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions LRG Levels
Interventions DIAGNOSTIC_TEST: serum leucine-rich alpha-2 glycoprotein (LRG) levels
Participant Information
Sponsor Showa Inan General Hospital
City Nagano
Country/Region Japan
Enrollment Criteria
Sex Requirement ALL
Age Requirement CHILD, ADULT, OLDER_ADULT
Study Design
Study Type OBSERVATIONAL
Phase NULL
Time Information
Start Date 2020-10-01
Primary Completion Date 2024-12-31
Completion Date 2024-12-31